A Phase I Study to Evaluate the Single and Multiple-dose Pharmacokinetics of Intravenous Trappsol Cyclo (HP-Beta-CD) in Patients With Niemann-Pick Disease Type C (NPC-1) and the Effects of Dosing Upon Biomarkers of NPC Disease
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Hydroxypropyl betadex (Primary)
- Indications Niemann-Pick disease type C
- Focus Biomarker; Pharmacokinetics
- Sponsors CTD Holdings
- 10 Jun 2017 Biomarkers information updated
- 16 May 2017 Details from this trial will be presented in a webinar hosted by the company, according to a CTD Holdings media release.
- 23 Mar 2017 Status changed from not yet recruiting to recruiting, according to a CTD Holdings media release.